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Purpose: The aim of this study is to assess the effectiveness, safety and reproducibility of the micro 
- ureteroscopy (m - URS) in the treatment of distal ureteral stones in women. 
Materials and Methods: A multicenter, prospective, observational study was designed and 
conducted between March and December 2015. We included women having at least one stone in 
the distal ureter and being a candidate for surgical treatment employing the 4.85 French sheath of 
Micro-Perc®. Patients with clinical criteria and/or laboratory analysis indicating sepsis, or 
coagulation alteration were excluded. 
Results: 39 women were operated in 8 hospitals. The profile of the patients was fairly 
homogeneous among hospitals. Only differences were found in age, preoperative stent and the 
result of the previous urine culture. Immediate stone-free status was achieved in 88.2% and 100% 
seven days after the procedure. 97.4 % of patients did not present any complication in the 
postoperative period, with only one case with complication Clavien II. PULS (Post-Ureteroscopic 
Lesion Scale) scale in 76.9 % of patients did not show any injury, 20.5% had lesions grade 1 and 
grade 2 lesions 2.6 %. As for the reproducibility of micro - ureteroscopy between hospitals, 
statistical analysis of the results showed differences between all the centers participating in the 
study. 
 
Conclusions: Micro-ureteroscopy is an effective, safe and reproducible technique that minimizes 
surgical aggression to the ureteral anatomy. Satisfactory and comparable results to “conventional” 
ureteroscopy were obtained in the treatment of distal ureteral stones in women, though clinical 
trials are needed. The reduction of the ureteral damage may reduce secondary procedures and 
increase the cost-effectiveness of the procedure. 
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Purpose: The aim of this study is to assess the effectiveness, safety and reproducibility of the micro 
- ureteroscopy (m - URS) in the treatment of pelvic ureter distal ureteral stones in women. 
Materials and Methods: A multicenter, prospective, observational study was designed and 
conducted between March and December 2015. We included women having at least one stone in 
the distal pelvic ureter and being a candidate for surgical treatment employing the 4.85 French 
sheath of Micro-Perc®. Patients with clinical criteria and/or laboratory analysis indicating sepsis, or 
coagulation alteration were excluded. 
Results: 39 women were operated in 8 hospitals. The profile of the patients was fairly 
homogeneous among hospitals. Only differences were found in age, preoperative stent and the 
result of the previous urine culture. Immediate stone-free status was achieved in 88.2% and 100% 
seven days after the procedure. 97.4 % of patients did not present any complication in the 
postoperative period, with only one case with complication Clavien II. PULS  scale(Post-
Ureteroscopic Lesion Scale) scale in 76.9 % of patients did not show any injury, 20.5% had lesions 
grade 1 and grade 2 lesions 2.6 %. As for the reproducibility of micro - ureteroscopy between 
hospitals, statistical analysis of the results showed statistically significant differences between all 
the centers participating in the study. 
 
Conclusions: Micro-ureteroscopy is an effective, safe and reproducible technique that minimizes 
surgical aggression to the ureteral anatomy. Satisfactory and comparable results to “conventional” 
ureteroscopy results that wereare comparable to “conventional” ureteroscopy wereare obtained 
in the treatment of pelvic distal ureteral stones in women, though clinical trials are needed. The 
reduction of the ureteral damage may reduce secondary procedures and increase the cost-
effectiveness of the procedure. 













































































































































































































































































































































































































































Title: Assessment of the effectiveness, safety and reproducibility of micro-ureteroscopy in the 
treatment of distal ureteral stones in women: a multicenter, prospective study. 
 
Introduction: 
Various factors explain the increase in the prevalence of urinary stone disease both in Spain and in 
other areas of Europe and the World1. There is also an increase in the direct and indirect spending 
expenses generated by this disease2. 
Ureteral stones generate the greatest morbidity. In these cases, tThe therapeutic options are to 
initiate medical treatment with the objective of spontaneous passage of the stone, medical 
expulsive therapy (MET), or to start active treatment, either with through extracorporeal shock 
wave lithotripsy (ESWL) or ureteroscopy (URS). AltThough medical expulsive therapyMET appears to 
be the most attractive option3, as the least interventional of all, its efficacy mightaybeis limited34 
even in stones smaller than 10 mm. Therefore, active treatment options for ureteral lithiasis are 
growing in popularity. 
The objective of ESWL is the external fragmentation of the stone, with the hope thatso the smaller 
fragments can then be spontaneously passed spontaneously by the patient. In the specific case of 
URS, the fragmentation or pulverization of the stone fragmentation occurs directly in the ureter, 
and its extraction is immediate. This is the primary advantage of URS over ESWL, at the expense of 
higher morbidity45. One of the major advances in endourology in order to reduce iatrogeny while 
maintaining efficacy, is the miniaturization of the endoscopic instruments. The use of smaller-
calibrer ureteroscopes reduces ureteral damage, the risk of complications and the need for post-
operative catheterization, thereby improving the patient’s quality of life after the procedure5-6-7. In 
2015, in this line of research, weour group published ourits first experience inwith the treatment of 
pelvic distal ureteral lithiasis in women using micro-ureteroscopy (m-URS) through with the 
retrograde use of the 4.85 Fr.78sheath from the micro-percutaneous (micro-PERC®) surgery set89. 
The aim of this study is to evaluate the effectiveness, safety and reproducibility of this technique in 
the treatment of pelvic distal ureteral stones in women. 
 
Materials and methods: 
Study design: 
A multicenter, prospective, observational study was designed and conducted between March and 
December 2015. The inclusion criteria were: being woman over 18 years of age, having at least one 
stone of any size in the distal pelvic ureter and being a candidate for surgical treatment according 
to the standard practice of each site, either scheduled or as an emergency. Patients with clinical 
criteria and/or analitycal laboratory analysis indicating sepsis criteria, patients with an irreversible 
coagulation clotting alterationdisorder, or patients who would not sign the informed consent to 
undergo the procedure were excluded. The ethical principles and recommendations of the 
Declaration of Helsinki were respected during this research. 













































































































































































































































































































































































































































The participating sites were IMQ Zorrotzaurre Clinic (Bilbao, Spain), Santiago de Compostela 
Universitary Hospital (A Coruña, Spain), Universitary General Hospital of Alicante (Alicante, Spain), 
La Paz Universitary Hospital (Madrid, Spain), La Fe Universitary and Politechnic Hospital (Valencia, 
Spain), La Ribera Universitary Hospital (Alzira, Spain), Rio Hortega Universitary Hospital (Valladolid, 
Spain) and Universitary Hospital of Vinalopo (Elche, Spain). 8 surgeons from different centers 
participated in the study. To achieve the objectives, bBetween 4 and 5 operations were performed 
atin each center.one of the 8 participating hospitals. Three of the eight study surgeons had prior 
experience in micro-ureteroscopy ranging from 5 to 10 cases each. The rest understood the 
material used and attended a workshop to learn the technique. 
Surgical technique: 
The 4.85 Fr. sheath from the Micro-Perc® set and the 10,000 pixel, 120 degrees, 0.9 mm diameter 
flexible optic system (Polydiagnost, Germany) (see Figures 1 and 2) were used for m-URS. A 3-arm 
luer lock adapter was connected to the sheath to insert the optics (through the middle arm), the 
irrigation (either with perfusion pump or gravity dripping) through one lateral arm, and the 230 
laser fiber through a Tuohy Borst Adapter (Cook®, USA) to avoid irrigation dripping through the 
third arm. 
The use of accessory materials (safety guidewire or 1.3 Fr. stone-basket), antibiotic prophylaxis 
protocols, anaesthesia techniques or the decision to insert a stent prior to surgery or afterwards 
was left to the surgeons’ criteria, according to their standard practice. Most of the times the sheath 
iswas inserted retrogradly in the ureter with neither need of meatus dilation nor safety 
guidewire.The entire procedure was performed under endoscopic vision (see Figure 3). Laser 
settings were adjusted to dust the stone and try avoiding the need for fragments removal. 
In those cases, in which the surgeon observed difficulty in completely treating the stone with m-
URS, the conventional ureteroscope could be used. We defined a “conventional” ureteroscope as 
that not designed “a priori” for use in pediatric patients (i.e. tip diameter greater than 7.5 Fr). 
The material used for the micro-ureteroscopy was the 4.85 Fr. sheath from the Micro-Perc® set 
(Polydiagnost) and the 10,000 pixel, 120 degrees, 0.9 mm diameter flexible optic system (see 
Figures1 and 2). In those cases, in which the surgeon observed difficulty in completely treating the 
lithiasis through micro-ureteroscopy, the conventional ureteroscope could be used. We define a 
“conventional” ureteroscope as that not designed “a priori” for use in pediatric patients, for which 
reason it has a tip diameter greater than 7.5 Fr. 
The 4.85 Fr. sheath is connected to the 3-Luer-Lock adapter. The 0.9 mm optic is inserted through 
the middle channel of the adapter. A Touhy Borst Adapter (Cook®, USA) is connected to a second 
channel, the laser fiber is inserted through this channel. Finally, the irrigation is connected to the 
third channel. Most of the times the sheath is placed retrogradly in the ureter with no need of 
meatus dilation and no need of safety guidewire. We performed the entire procedure under direct 
vision. 
The saline infusion method was used with a perfusion pump or gravity drip, as per the site. The use 
of accessory materials (safety guidewire or 1.3 Fr. stone-basket), antibiotic prophylaxis protocols, 













































































































































































































































































































































































































































anaesthesia techniques or the decision to insert a stent prior to surgery or afterwards was left to 
the surgeon’s criteria, according to his or her standard practice. 
Laser settings were adjusted to pulverize the stone and avoid the need of removing fragments. 
Study variables: 
The independent variables consisted of the following data: age, sex, body mass index (BMI), 
diabetes history, use of antiplatelet or anticoagulant drugs, ASA classification, possible 
genitourinary malformations, characteristics of the stones, previous treatments for ipsilateral 
lithiasis and the result of the previous culture. 
The primary endpoints are encompassed under the study objectives: The effectiveness of the 
procedure was assessed through the number of immediately stone-free cases as observed through 
endoscopic and/or fluoroscopic study (see Figure 4) after the procedure, and 7 days after the 
intervention through KUB x-ray of the abdomen. The safety of the technique was evaluated through 
the incidence of complications, using the modified Clavien-Dindo scale, and through the analysis of 
any ureteral damage caused, with the Post-Ureteroscopic Lesion Scale, or PULS. In all cases a renal 
ultrasonography and/or a computed tomography waswere performed 3 to 6 months after the 
procedure. 
Other variables were the use or not of cystoscope, safety guidewires, “conventional” ureteroscope 
or urinary catheter during the procedure. The duration of the intervention and the need to convert 
the procedure to conventional ureteroscopy, as well as the reason, the need to use post-operative 
ureteral stent, and its duration were also recorded. 
Statistical analysis: 
The primary study variables were summarized using means as measures of central tendency and 
the 95% confidence interval (CI95%) as measure of dispersion for the quantitative variables, 
and frequencies and percentages for the qualitative measures. 
For the study of the reproducibility or homogeneity of the procedure, percentages were calculated 
for the qualitative variables for each one of the hospitals. To discuss the possible differences 
between the hospitals, the non-parametric statistics Chi-Square Distance, symmetrical Lambda and 
the Goodman-Kruskal Tau were calculated. In the case of quantitative variables, medians per 
hospital were calculated. The non-parametric Kruskal-Wallis (KW) statistic was used to obtain 
possible differences between hospitals, in addition to the parametric, single-factor ANOVA 
procedure. The statistical package used was the SPSS 15.0 program. 
The lack of data per hospital can call into question the assumptions of normality and 
homoscedasticity, but not independence, for the application of ANOVA, though the solidity of the 
method in the face of this lack of homoscedasticity of requirements is known in cases where the 
sample size from each hospital is practically equal. 
To perform the analysis of the homogeneity of the results between the different hospitals, the sites 
that were required to use the cystoscope to remove a ureteral stent prior to the current procedure 
were excluded. A decision was made to also exclude the site that systematically uses a safety 













































































































































































































































































































































































































































guidewire to perform the procedure and the site that, per protocol, leaves any ureteral stent 
inserted in situ for 14 days. 
 
Results: 
The demographic characteristics of the study population are reflected in Table 1. The patient profile 
was fairly homogeneous among the hospitals (Table 2). Differences were only observed in age, 
having a preoperative stent and the result of the previous culture. While in one hospital the median 
age was 37 years, in another, it stood at 79 years. In half of the sites, no patients had preoperative 
stents, while in two sites, 4 and 3 women, respectively, had preoperative stents in place. Finally, in 
3 hospitals, the previous culture was negative in all cases and, in another, all of the cultures were 
positive. 
Previous treatments included 6 ESWL performed no more than one month previous to the micro-
ureteroscopy, 1 case of retrograde intrarenal surgery and a percutaneous nephrolithotomy each. 
Finally, in two cases an ipsilateral ureteroscopy was done more than 4 years ago and in 1 case the 
URS was performed 2 weeks prior m-URS.  
Regarding how each surgeon's appliedpreferences for the m-URSicro-ureteroscopy technique (see 
Table 3), the cystoscope was chosen in 2 of the 27 cases not previously having a bearing double-J 
stent. In 94.3% (86.6%-100%) the meatus was accessed directly, with no safety guidewire. In 
4 patients, 10.3% (0.8-19.8%) of the total, the conventional ureteroscope had to be used. The 
reasons for using the ureteroscope were, in 3 cases, poor image quality and, in 1 case, the inability 
to mobilize an impacted stone using the m-URS equipment. In no case was it necessary to convert 
due to stone retropulsionmigration of the stone to a level of the ureter where, due to the 
sheath´sits length, the stone was not accessiblereachablesheath of the m-URS could not access. 
In 35 patients (89.7%) of cases, the stone was fragmented dusted using the Holmium laser. In 
6 renal units, a double-J stent was inserted and, in 5, an external straight ureteral stentrectal 
ureteral stent was inserted for 24 hours. The ureteral stents were maintained for a mean of 3.5 
days. The mean duration of the surgery was 35.8 minutes (CI95% 29.3-42.2). 
In terms of the effectiveness of m-URS, 30 patients (88.2%) were stone-free immediately and 100% 
were stone-free one week after the procedure. No retreatment was required in any case. 
Regarding the safety of the technique, 97.4% of the patients presentshowed no problems of any 
kind during the postoperative period, with a single case with Clavien II complication. On the PULS 
scale, 76.9% of patients did not present any lesion, 20.5% presented grade 1 lesions and 2.6% 
presented grade 2 lesions. The renal ultrasonography and/or the computed tomography performed 
3 to 6 months after the procedure demonstrated no hydronephrosis. 
With respect to the reproducibility of the micro-ureteroscopy between among hospitals, the results 
analysis for the intervention revealed no statistically significant differences between the sites 
participating in the study (Table 4). Moreover, no differences were found between novel and 
experienced surgeons (Table 1 and 3). 















































































































































































































































































































































































































































According to the American Urological Association (AUA) and the European Association of Urology 
(EAU) guidelines, patients with ureteral stones under 6 mm, or even under 10 mm, can be offered 
conservative medical management provided there are no complication criteria9,10,11. 
Male patients were excluded from this study since the urethral length and its curve at the prostate 
levelanatomy limit the instrumentation with the micro-ureteroscopy sheath, with its reduced length 
(22.5 cm) and caliberre. The upper limit in women is L5-S1 level, in men the limit is being the sciatic 
spine and, in children, according to the age we can even reach the renal pelvis. With respect to the 
characteristics of the patients Patients treated, the age was higher than in the majority of 
the studies consulted1112. The level of comorbidity and body mass index (BMI) wereas 
comparable to that of other series. 
With respect to the results of the micro-ureteroscopy, tThe surgical time in our study with micro-
ureteroscopy (35.8 minutes) was shorter than that published by the CROES with “conventional” 
ureteroscopy (42.2 min). This couldcan be explained by a smaller mean surface area of the stones 
treated in our series (33.3 mm2 versus 66.6 mm2)1213. 
Except forin those patients with ureteral stent prior to the intervention or in the cases in which 
safety guidewires were used per protocol, the use of a cystoscope was only required in two cases to 
perform the micro-ureteroscopy. Therefore, with respect to standard practice, in these specific 
cases, m-URS could involve an increase of instrumentation. used versus ureteroscopy. 
AltThough guidelines recommend the use of safety guidewires9,10,11, some authors have already 
published studies comparingpreviously compared the complications with and without their use1314. 
In our study, each surgeon was free to use a safety guidewirethem or not. This Guidewires could be 
inserted through the very 4.85 Fr. sheath with fluoroscopic guidance or prior to the insertion of the 
sheath with a cystoscope. In this study, tThe meatus was accessed with no guidewire in 85% of all 
cases. One of the sites decided to follow the recommendations of the guidelines and employed the 
safety guidewire in 75% of its cases. In the rest of the sites, only 2 surgeons, in 1 procedure each, 
observed a need to use the safety guidewire it during the treatment of the stone. 
The reduced diameter of the sheath makes the distance between it and the ureteral wall greater. 
Therefore, the risk of damaging the meatus or the intramural ureter could be lower with m-URS. 
The micro-ureteroscopy sheath only allows us to work with laser fibers between 230 and 270 
microns (classic tip, not round), while “conventional” ureteroscopy allows for the use of wider fibers 
with a greater calibre. The existing studies are not conclusive regarding whether or not the 
diameter of the fiber affects the capacity to fragment the stone14,15,16. In any case, we consider its 
performance to be sufficient to treat the lithiasis in an acceptable period of time. In the study by 
Galán et al.1617 the mean surface area of the stones treated was 33 mm2, which is very similar to 
ours, with a greater longer surgical time, at 42 minutes. It should be noted that the majority of the 
sites participating in the study were experts in ureteroscopy, but that this was their first contact 
with micro-ureteroscopy. 













































































































































































































































































































































































































































The use of the conventional ureteroscope was due to poor image quality in 3 out of 4 cases. It is 
important to note that this circumstance always All of them occurred in the same site. This leads us 
to believe that it could be due to an isolated failure of the site’s m-URS equipment. 
Though there were 15 impacted stones, the use of the “conventional” ureteroscope was only 
required to treat the stone in one case. The frequency of impacted stones in our series (38.5%) is 
higher than that published by the CROES (29.2%) for distal ureter lithiasis, 38.5% in our study versus 
29.2% in the CROES study1213. This is an independent factor for the increasinge of postoperative 
complications1718. 
It is remarkable that starting treatment with m-URS did not impede the successful completion of 
the procedure in any case. Therefore, no patients required retreatment. 
In terms of About the effectiveness of the micro-ureteroscopym-URS, the immediate success of the 
treatment was homogeneous among the different sites. One of the sites did not classify any of its 
cases as immediately stone-free. This site considered that no patient couldan be declared stone-
free right at the time the procedure is was finalized. In the rest of the hospitals, there was 
consensus to classify all of the patients as were stone-free 7 days after treatment. This result is in 
line with the results of conventional ureteroscopy in the treatment of distal ureteralpelvic ureter 
lithiasis1819. 
To measure the safety of micro-ureteroscopy, the adaptation of the Clavien-Dindo classification was 
used19-2120-22 for postoperative complications. A total of 97.4% of patients did not present any 
complications, and there was only one case of a grade 2 complication (postoperative fever that was 
resolved with endovenous antibiotic treatment). The study by Pérez-Castro et al. for the 
Endourological Society, in which 9681 patients were included, presented 3.8% intraoperative 
complications and 2.4% postoperative complications for distal ureter stones. 
In our case, the grade 2 complication in the Clavien Dindo scale was one case of postoperative fever 
that was resolved with endovenous antibiotic treatment. 
Moreover, we used the PULS scale2223, to assess ureteral damage, caused by either the surgical 
intervention or by the ureteral stoneinary lithiasis itself. However, the series published to date 
differ regarding the characteristics of the stones treated; therefore, those results are not 
comparable to ours22-2423-25. It would be advisable to reach an agreement on the adoption of this 
scale in results the reporting of results from different groups. 
The postoperative ureteral stent is a factor that independently affects patient quality of life25,26,27. 
The study conducted by the CROES for the treatment of ureteral lithiasis, with respect to distal 
ureteral lithiasis, indicated that showed that a double-J ureteral stent was inserted in 54.7% of the 
cases1213 despite multiple studies certifying that a ureteral stent is not to be used systematically in 
uncomplicated ureteroscopies27-2928-30. Moreover, Caballero et al. presented their results in a 
prospective-retrospective study and described a reduction in the insertion of ureteral stents in 
patients treated with micro-ureteroscopy versus patients treated with ureteroscopy using a 
7.5-9.5 Fr. ureteroscope3031. In our casesstudy, a ureteral stent was inserted in 17.1% of the cases. 
This highly favorable result may be due to the smaller size of the stone treated or to the reduced 
size of the micro-ureteroscopy sheath; in any case, further studies are needed to make draw any 
conclusions in this regard. 













































































































































































































































































































































































































































During the study, each urologist was surgeons were able to follow his theiror her standard practice 
and, at one site, the duration of the ureteral catheterization was always 14 days, regardless of the 
degree of ureteral lesion observed. Since some authors2223 establish that each degree of ureteral 
lesion requires a different duration of ureteral catheterization, this is not always possible due to the 
healthcare or administrative circumstances of each site. 
The statistical analysis of the results by site demonstrateds the homogeneity of the micro-
ureteroscopy technique. No significant differences were found in the technical variables or in the 
results of the technique across the hospitals participating in the study, therefore, the result could 
suppose the homogeneity of the micro-ureteroscopy technique.. 
The primary limitations of the study wereare the reduced sample size, though the multicenter 
nature of the study reinforces the reproducibility data found. The non-use of a standardized 
protocol may seem to be a limitation of this study, but in the authors’ opinion, it shows that the 
technique is feasible regardless of the procedure used and its variations. Another limitation of the 
study might be the inability to determine the cost-effectiveness of the procedure. The sheath is a 
disposable device. Its cost is about 400 US dollars. In any case reducing the ureteral damage could 
reduce the readmission rate, the rate of inpatient procedures, the need of secondary procedures 
and/or the use of analgesics. 
Conclusions: 
Micro-ureteroscopy is an effective, safe and reproducible technique that minimizes surgical 
aggression to the ureteral anatomy. Satisfactory results that are cComparable results to 
“conventional” ureteroscopy are obtained in the treatment of distal pelvic ureteral stones in 
women, though clinical trials comparing the two techniques are needed to assess any advantages 
or disadvantages. The reduction of the ureteral damage may reduce secondary procedures and 











BMI: Body mass index 
















































































































































































































































































































































































































































KUB x ray: Kidney Ureter and bladder X-ray 
PULS: Postureteroscopic lesion scale 
CI: confidence interval 
AUA: American Urological Association 
EAU: European Association of Urology 



















































































































































































































































































































































































































































Figure 1. Equipment used in micro-ureteroscopy: 1- 0.9 mm diameter optic; 2- 3 Luer Lock adapter; 
3- Tuohy Borst Adapter; 4- Optic adapter; 5- Irrigation channel; 6- 4.85F sheath of MicroPerc set. 
 
  















































































































































































































































































































































































































































Figure 2. Material prepared for micro-ureteroscopy. 
 
  















































































































































































































































































































































































































































Figure 3. Endoscopic image during the procedure before starting dusting a stone. 
 
  















































































































































































































































































































































































































































Figure 4. Intraoperative fluoroscopy, in which the sheath for micro-ureteroscopy is identified inside 
the left ureter during the treatment of a distal ureteral stone. 
 
  





















































































































































































































































































































































































































































surgeons (n = 24) 
N (%) 
Experienced 
surgeons (n = 15) 
N (%) 
Age (years old) 39 56.18  (50.9 - 61.4) 55.7¶ 56.9¶ 
BMI (kg/m2)  36 26.21  (24.3 - 28.1) 26.6¶ 25.5¶ 
Diabetes 38  6 (15.8) (4.2 - 27.4) 3 (12.0%) 3 (21.4) 
Antiplatelet drugs 38  1 (2.6) (0.0 - 7.7) 1 (4.2%) 0 (0.0) 
Anticoagulant 38  1 (2.6) (0.0 - 7.7) 0 (0.0) 1 (7.1) 
ASA Classification 39       
I   12 (30.8) (16.3  - 45.3) 9 (37.5) 3 (20.0) 
II   21 (53.8) (38.2 - 69.4) 12 (50.0) 9 (60.0) 
III   6 (15.4) (4.1 - 26.7) 3 (12.5) 3 (20.0) 
Genitourinary Malformations  38  0 (0.0) -  - - 
Side 37       
Left   17 (45.9) (29.8 - 62.0) 11 (47.8) 6 (42.9) 
Right   20 (54.1) (38.0 -70.2) 12 (52.2) 8 (57.1) 
Previous treatments of 
ipsilateral stones 
38  11 (28.9) (14.5 - 43.3) 
8 (33.3) 3 (21.4) 
Major diameter (mm.) 38 7.63  (6.6  - 8.7) 7.5 7.9 
Surface of the stone (mm2) 38 33.35  (25.1 - 41.56) 31.5 36.5 
Preoperative stent 39  9 (23.1) (9.9 - 36.3) 9 (37.5) 0 (0.0) 
Impacted stone 39  15 (38.5) (23.2 - 53.8) 8 (33.3) 7 (46.7) 
Previous urinary culture  30       
Negative   23 (76.7) (61.6 - 91.8) 15 (71.4) 8 (88.9) 
Positive   7 (17.9) (4.2 - 31.6) 6 (28.6) 1 (11.1) 
BMI: body mass index; ASA: American Society of Anesthesiologists. Quantitative variables are expressed as mean 




















































































































































































































































































































































































































































Table 2:  Patient characteristics in each center 
 















































ASA Classification              









II  2/5 3/5 3/5 3/4  3/5 1/5 2/5 4/5  
III  1/5 0/5 1/5 0/4 1/5 2/5 0/5 1/5  
Genitourinary 
Malformations  
0/5 0/5 0/5 0/4 0/5 0/5 0/5 0/5 - - -  
 
Side               








Right  3/5 3/5 1/4 2/4  1/4  3/5 3/5 4/5  
Previous treatments of 
ipsilateral stones 
















Surface of the stone 
(mm2(median)) 



























Previous urinary culture               












Positive  1/4 1/5 -/- 0/4 2/4 3/3 0/5 0/5  
 
BMI: body mass index; ASA: American Society of Anesthesiologists. 
Est1.: Chi-square, λ: Simmetric Goodman and Kruskal Lambda, τ.: Hospital independent Goodman and Kruskal Tau. K-W:  Chi-
Square Kruskal-Wallis, df: degrees of freedom. (P-V): P-value. ¥ statistically significant value. 
 
 













































































































































































































































































































































































































































Table 3: Technical aspects and results of surgery and analysis according to 
surgeons’ experience 
  





surgeons           
(n = 24) 
N (%) 
Experienced 
surgeons           
(n = 15)              
N (%) 
Use of cystoscope* 27  2 (7.4) (0.0 -17.3) 2 (16.7)  
Ureteral meatus access 35       
Direct   33 (94.3) (86.6 -100) 18 (90.0) 15 (100.0) 
Guidewire   2 (5.7) (0.0 -13.4) 2 (10.0) 0 (0.0) 
Dilatation   0 (0.0)   0 (0.0) 0 (0.0) 
Use of “conventional” URS 39  4 (10.3) (0.8 -19.8) 3 (12.5) 1 (6.7) 
Stone fragmentation 39  35 (89.7) (80.2 -99.2) 21 (87.5) 14 (93.3) 
Upper stone migration 37  0 (0)   0 (0) 0 (0) 
Operative time (minutes) 39 35.8  (29.3 -42.2) 31.1 43.3 
Postoperative stent 35       
None   24 (68.6) (53.2 -84.0) 15 (75.0) 9 (60.0) 
External straight stent   5 (14.3) (2.7 -25.9) 3 (15.0) 2 (13.3) 
Double J stent   6 (17.1) (4.7 -29.6) 2 (10.0) 4 (26.7) 
Total time of stenting (days)  39 3.5  (1.5 -5.4) 3.2 3.9 
Clavien -Dindo scale                                                    
 
39 
      
 
38 (97.4) (92.4 -100.0) 
  
0 23 (95.8) 15 (100.0) 
I   0 (0)   0 (0.0) 0 (0.0) 
II   1 (2.6) (0.0 -7.6) 1 (4.2) 0 (0.0) 
PULS 39       
0   30 (76.9) (63.7 -90.1) 20 (83.3) 10 (66.7) 
1   8 (20.5) (7.8 -33.2) 3 (12.5) 5 (3.33) 
2   1 (2.6) (0.0 -7.6) 1 (4.2) 0 (0.0) 
Inmediate stone-free status 34  30 (88.2) (77.4 -99.1) 15 (79.9) 15 (100.0) 
*Measures calculated on the number of patients not previously carrying a double J stent. URS: 
ureteroscope; PULS: post-ureteroscopic lesion scale.  
Quantitative variables are expressed as mean and 95% confidence interval (95%), while qualitative do in 



















































































































































































































































































































































































































































Table 4:  Technical aspects and results of the surgery in each center 
 




















Ureteral meatus access              









Guidewire 0/5 1/5 0/5 -/- 1/5 0/5 0/5 0/5  
Dilatation 0/5 0/5 0/5 -/- 0/5 0/5 0/5 0/5  


















Operative time in minutes 
(median) 





Upper stone migration 0/5 0/5 0/5 0/4 0/5 0/5 0/5 0/5 - - -   
Postoperative stent              









External straight stent 0/5 1/5 1/5 -/- 1/5 0/5 1/5 1/5  
Double J stent 2/5 1/5 2/5 -/- 0/5 0/5 1/5 0/5  
Total time of stenting 
(days) (median)** 





Clavien -Dindo scale                                                                









I 0/5 0/5 0/5 0/4 0/5 0/5 0/5 0/5  
II 0/5 0/5 0/5 0/4 1/5 0/5 0/5 0/5  
PULS              









1 1/5 1/5 2/5 0/4 2/5 0/5 0/5 2/5  
2 0/5 0/5 0/5 0/4 0/5 1/5 0/5 0/5  
Inmediate stone-free 
status 










* Measures calculated among patients not previously carrying a double J stent. **Median calculated among patients with a 
postoperative stent in each center. URS: ureteroscope; PULS: post-ureteroscopic lesion scale. 
Est1.: Chi-square, λ: Simmetric Goodman and Kruskal Lambda, τ.: Hospital independent Goodman and Kruskal Tau. K-W:  Chi-
Square Kruskal-Wallis, df: degrees of freedom. (P-V): P-value. ¥  Statistically significant value. 
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